These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24764317)

  • 41. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin.
    Evjen TJ; Hagtvet E; Nilssen EA; Brandl M; Fossheim SL
    Eur J Pharm Sci; 2011 Jul; 43(4):318-24. PubMed ID: 21620968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposomal nanomedicines in the treatment of prostate cancer.
    Kroon J; Metselaar JM; Storm G; van der Pluijm G
    Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.
    Jain AS; Goel PN; Shah SM; Dhawan VV; Nikam Y; Gude RP; Nagarsenker MS
    Biomed Pharmacother; 2014 May; 68(4):429-38. PubMed ID: 24721327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Light-Triggered Cancer Cell Specific Targeting and Liposomal Drug Delivery in a Zebrafish Xenograft Model.
    Kong L; Chen Q; Campbell F; Snaar-Jagalska E; Kros A
    Adv Healthc Mater; 2020 Mar; 9(6):e1901489. PubMed ID: 32052583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA; Polo D; Reig F; Fabra A
    J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. pH sensitive coiled coils: a strategy for enhanced liposomal drug delivery.
    Reja RM; Khan M; Singh SK; Misra R; Shiras A; Gopi HN
    Nanoscale; 2016 Mar; 8(9):5139-45. PubMed ID: 26876788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Building and characterizing antibody-targeted lipidic nanotherapeutics.
    Kirpotin DB; Noble CO; Hayes ME; Huang Z; Kornaga T; Zhou Y; Nielsen UB; Marks JD; Drummond DC
    Methods Enzymol; 2012; 502():139-66. PubMed ID: 22208985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlations between the rate of intracellular release of endocytosed liposomal Doxorubicin and cytotoxicity as determined by a new assay.
    Kirchmeier MJ; Ishida T; Chevrette J; Allen TM
    J Liposome Res; 2001; 11(1):15-29. PubMed ID: 19530916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual ATP/reduction-responsive polyplex to achieve the co-delivery of doxorubicin and miR-23b for the cancer treatment.
    Tang X; Liang X; Wen K; Chen Y; Han H; Li Q
    Colloids Surf B Biointerfaces; 2021 Oct; 206():111955. PubMed ID: 34216852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system.
    Tripathy N; Ahmad R; Ko HA; Khang G; Hahn YB
    Nanoscale; 2015 Mar; 7(9):4088-96. PubMed ID: 25660501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A smart ATP-responsive chemotherapy drug-free delivery system using a DNA nanostructure for synergistic treatment of breast cancer
    Abnous K; Danesh NM; Ramezani M; Alibolandi M; Bahreyni A; Lavaee P; Moosavian SA; Taghdisi SM
    J Drug Target; 2020; 28(7-8):852-859. PubMed ID: 31916879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermosensitive liposomal drug delivery systems: state of the art review.
    Kneidl B; Peller M; Winter G; Lindner LH; Hossann M
    Int J Nanomedicine; 2014; 9():4387-98. PubMed ID: 25258529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape.
    Xu H; Zhang W; Li Y; Ye FF; Yin PP; Yu X; Hu MN; Fu YS; Wang C; Shang de J
    Pharm Res; 2014 Nov; 31(11):3038-50. PubMed ID: 24805279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.